Published in J Immunol on December 01, 1985
The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Escherichia coli GroEL protein. Infect Immun (1988) 5.03
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev (1992) 4.58
The continuing challenges of leprosy. Clin Microbiol Rev (2006) 4.09
Genes for the major protein antigens of Mycobacterium tuberculosis: the etiologic agents of tuberculosis and leprosy share an immunodominant antigen. Proc Natl Acad Sci U S A (1987) 2.79
The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG. Infect Immun (1987) 2.66
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Screening of a recombinant mycobacterial DNA library with polyclonal antiserum and molecular weight analysis of expressed antigens. Infect Immun (1987) 1.74
Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun (1987) 1.73
T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect Immun (1994) 1.59
Isolation and restriction site maps of the genes encoding five Mycobacterium tuberculosis proteins. Infect Immun (1987) 1.47
Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun (1991) 1.45
Identification, sequencing, and expression of Mycobacterium leprae superoxide dismutase, a major antigen. Infect Immun (1990) 1.37
Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens. J Clin Microbiol (1986) 1.28
Cellular immune responses of leprosy contacts to fractionated Mycobacterium leprae antigens. Infect Immun (1989) 1.17
The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy. J Exp Med (1991) 1.17
A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae. Infect Immun (1996) 1.17
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
Recognition of mycobacterial antigens by sera from patients with leprosy. J Clin Microbiol (1988) 1.08
Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Clin Exp Immunol (1988) 1.05
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04
A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion. Infect Immun (1998) 1.02
T cell reactivity to the purified mycobacterial antigens p65 and p70 in leprosy patients and their household contacts. Clin Exp Immunol (1990) 1.01
Production of a monoclonal antibody specific for Mycobacterium avium and immunological activity of the affinity-purified antigen. Infect Immun (1989) 1.00
Sequence and immunological characterization of a serine-rich antigen from Mycobacterium leprae. Infect Immun (1993) 0.94
The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect Immun (1992) 0.92
Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein. Infect Immun (1993) 0.89
Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes. Infect Immun (1997) 0.85
MPB70 and MPB83 as indicators of protein localization in mycobacterial cells. Infect Immun (1998) 0.85
Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae. Infect Immun (1996) 0.85
Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen. Clin Exp Immunol (1993) 0.83
Lack of cytotoxic activity against Mycobacterium leprae 65-kD heat shock protein (hsp) in multibacillary leprosy patients. Clin Exp Immunol (1995) 0.82
Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein. Clin Exp Immunol (2000) 0.82
Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy. Clin Exp Immunol (1992) 0.80
Limiting-dilution analysis of T cell reactivity to mycobacterial antigens in peripheral blood and synovium from rheumatoid arthritis patients. Clin Exp Immunol (1992) 0.77
Exposure to mycobacteria primes the immune system for evolutionarily diverse heat shock proteins. Infect Immun (2005) 0.76
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature (1986) 3.51
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy (1987) 2.81
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun (1999) 2.57
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med (2001) 1.74
An inducible expression system permitting the efficient purification of a recombinant antigen from Mycobacterium smegmatis. FEMS Microbiol Lett (1998) 1.70
Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66
Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect Immun (2001) 1.60
T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect Immun (1994) 1.59
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immunol (1996) 1.54
Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy (2002) 1.51
Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect Immun (1999) 1.49
Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49
Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48
Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J Immunol (2000) 1.47
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells. Eur J Immunol (1999) 1.44
Prevalence of bronchial hyperresponsiveness in children: the relationship between asthma and skin reactivity to allergens in two communities. Int J Epidemiol (1986) 1.43
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis. J Infect Dis (1994) 1.36
A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35
Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J Immunol Methods (1994) 1.33
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. III. Effect of exposure to environmental allergens. Clin Allergy (1987) 1.30
Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26
Bronchial hyperresponsiveness in two populations of Australian schoolchildren. II. Relative importance of associated factors. Clin Allergy (1987) 1.25
The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18
Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17
The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy. J Exp Med (1991) 1.17
A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae. Infect Immun (1996) 1.17
Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses. Int J Lepr Other Mycobact Dis (1990) 1.16
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
CD4+ and CD8+ T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guérin. J Infect Dis (2000) 1.15
B cell life span: a review. Immunol Cell Biol (1997) 1.15
Suppressor cells in humoral immunity and tolerance. Br Med Bull (1976) 1.14
Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14
Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur J Immunol (1997) 1.14
Cell interactions in the immune response in vitro. I. Metabolic activities of T cells in a collaborative antibody response. Eur J Immunol (1972) 1.13
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol (2000) 1.12
B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12
Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study. Allergy (1996) 1.12
Immunological specificity and memory in a scleractinian coral. Nature (1977) 1.12
The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12
Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11
Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. Scand J Immunol (1996) 1.10
Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10
Suppressor T-cell memory. Nature (1978) 1.10
Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A (1991) 1.09
Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol (1980) 1.09
Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09
Characterization of the gene encoding the immunodominant 35 kDa protein of Mycobacterium leprae. Mol Microbiol (1995) 1.09
The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol (1997) 1.08
Post-mammoplasty connective tissue disease. Arthritis Rheum (1982) 1.08
Early predictors for developing allergic disease and asthma: examining separate steps in the 'allergic march'. Clin Exp Allergy (2007) 1.07
T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin Exp Immunol (2004) 1.06
Analysis of the internal transcribed spacer regions of ribosomal DNA in common airborne allergenic fungi. Electrophoresis (1997) 1.06
Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Clin Exp Immunol (1988) 1.05
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04